Close

Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Q3/11: Tali NDA on Track, Cerezyme Shortage Continues Nov 9, 2011 09:33AM
Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Tali FDA Approval on Track for Feb'12 Oct 19, 2011 09:01AM
Canaccord Genuity on Life Sciences/Biotechnology: FDA �Flexibility� May Add To Advantages of Orphan Drugs in Today's Market Oct 17, 2011 09:51AM
Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); New Tali PDUFA: Feb. 2012; EU Approval on Track for Q2/12 Aug 18, 2011 08:52AM
Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Resubmission Soon: FDA Focus on Full Switch Data, Not CMC Jul 25, 2011 08:40AM


May 5, 2011 12:13PM Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Q1/11: Positive FDA Meeting, PLX to Resubmit Tali in Mid-2011
Feb 9, 2011 11:54AM Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Expect Tali Data at WORLD to Back Approval, Clean Label
Jan 6, 2011 11:01AM Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); Predict Timely US Approval on PDUFA
Nov 30, 2010 10:49AM Canaccord Genuity Reiterates a 'Buy' on Protalix BioTherapeutics (PLX); EU Approval Application In: tali EMEA OK Possible By Early 2012
Jun 9, 2010 11:01AM Canaccord Genuity maintains a 'Buy' on Protalix BioTherapeutics (PLX); PLX-105 Moves Ahead, More Proof of Concept for Platform
Jun 4, 2010 10:49AM Canaccord Genuity Maintains a 'Buy' on Protalix BioTherapeutics (PLX); CMC Headline Risk May Not Impact Approvability